Differential inhibition of DNA polymerase and RNase H activities of the reverse transcriptase by phosphonoformate
- PMID: 6178013
- DOI: 10.1007/BF00423097
Differential inhibition of DNA polymerase and RNase H activities of the reverse transcriptase by phosphonoformate
Abstract
Three potential inhibitors of reverse transcriptase activities, phosphonoformate (PF), phosphonoacetate (PAA), and ethyl-diethyl phosphonoformate (Et-PF), were compared in this study. Only PF was found to inhibit the DNA polymerase activity of the purified reverse transcriptase of Moloney murine leukemia virus (M-MuLV) and avian myeloblastosis virus (AMV). The degree of DNA polymerase inhibition was linear with PF concentration; 50% inhibition was achieved at 10 muM. Whereas PF inhibited both the RNA and DNA dependent DNA polymerase activities, the RNase H activity of the reverse transcriptase was unaffected. Both the endogenous DNA polymerase activity in detergent disrupted virus and the activity of the purified enzyme with the isolated virus genome 70S RNA were inhibited by PF. However, higher concentrations of PF were needed to inhibit the endogenous reaction. The inhibition by PF appeared to be reversible and noncompetitive with respect to the substrate deoxythymidine triphosphate (dTTP). Addition of PF after the initiation of DNA synthesis immediately arrested the reaction.
Similar articles
-
Phosphonoformate inhibits reverse transcriptase.J Gen Virol. 1979 Nov;45(2):273-81. doi: 10.1099/0022-1317-45-2-273. J Gen Virol. 1979. PMID: 94344
-
Inhibition of human T-cell lymphotropic virus type III in vitro by phosphonoformate.Lancet. 1985 Jun 29;1(8444):1480-2. doi: 10.1016/s0140-6736(85)92255-x. Lancet. 1985. PMID: 2409414
-
Inhibition of hepatitis-B-virus DNA polymerase by phosphonoformate: studies on its mode of action.J Med Virol. 1980;5(4):309-16. doi: 10.1002/1096-9071(1980)5:4<309::aid-jmv1890050407>3.0.co;2-l. J Med Virol. 1980. PMID: 6453206
-
Antiviral effects of phosphonoformate (PFA, foscarnet sodium).Pharmacol Ther. 1982;19(3):387-415. doi: 10.1016/0163-7258(82)90074-2. Pharmacol Ther. 1982. PMID: 6201932 Review. No abstract available.
-
Mechanism of action of foscarnet against viral polymerases.Am J Med. 1992 Feb 14;92(2A):3S-7S. doi: 10.1016/0002-9343(92)90329-a. Am J Med. 1992. PMID: 1371038 Review.
Cited by
-
Domain structure of the Moloney murine leukemia virus reverse transcriptase: mutational analysis and separate expression of the DNA polymerase and RNase H activities.Proc Natl Acad Sci U S A. 1988 Mar;85(6):1777-81. doi: 10.1073/pnas.85.6.1777. Proc Natl Acad Sci U S A. 1988. PMID: 2450347 Free PMC article.
-
Use of recombinant retroviruses to characterize the activity of antiretroviral compounds.J Virol. 1991 Nov;65(11):6339-42. doi: 10.1128/JVI.65.11.6339-6342.1991. J Virol. 1991. PMID: 1920637 Free PMC article.
-
The potential of nucleotide analogs as inhibitors of retroviruses and tumors.Pharm Res. 1984 Jan;1(1):11-8. doi: 10.1023/A:1016370407633. Pharm Res. 1984. PMID: 24277178
-
Visna virus as an in vitro model for human immunodeficiency virus and inhibition by ribavirin, phosphonoformate, and 2',3'-dideoxynucleosides.Antimicrob Agents Chemother. 1987 Sep;31(9):1369-74. doi: 10.1128/AAC.31.9.1369. Antimicrob Agents Chemother. 1987. PMID: 2445282 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources